Health providers have an opportunity to further their education

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

If you are a healthcare provider and want to understand how managed care operates within the South Texas Market, this is a must-attend lunch & learn workshop presented by the experts in the field.

Please register at your earliest convenience to take advantage of this unique opportunity.

The Evolving Healthcare Market in South Texas

- Advertisement -

Course Objectives:

§  Understand current evolution of South Texas Healthcare market place

§  Quality initiatives undertaken by Managed Care Organization (MCOs)

§  Pay for Performance concept and how it affects healthcare practice.

- Advertisement -

§  Become familiar with the Medicaid and its future evolution

·         Become prepared to adapt and thrive within a managed care market place

The Evolving Healthcare Market in South Texas – Managed Care and Its Influence in Quality of Care Outcomes

Summary

This workshop will provide a basic understanding of the fundamentals of how managed care operates within the South Texas Market and how through the implementation of quality based initiatives, it strives to affect positive outcomes in the populations served. The participants will be able to gain insight to future market trends that will include compensation models based on quality outcomes.

Course Objectives:

  • Understand current evolution of South Texas Healthcare market place
  • Quality initiatives undertaken by Managed Care Organization (MCOs)
  • Pay for Performance concept and how it affects healthcare practice.
  • Become familiar with the Medicaid and its future evolution
  • Become prepared to adapt and thrive within a managed care market place

Course Date

September 10th, 2014 from 11:30 a.m.– 1 p.m.

Who Should Attend?

  • Physicians & mid-level practitioners.
  • Practice Managers
  • Rehab Facilities.
  • Ancillary Providers.
  • Home Health and Hospice providers.
  • DMEs’.
  • Any medicare or medicaid provider.

Are You Ready for a Visit from the OIG? (Office of Inspector General)

Summary

This course will provide a basic understanding of the fundamentals of a health care compliance program and the penalties for not having one in place. The participants will become familiar with various governmental agencies, contractors involved in enforcement and recent levied penalties.

Course Objectives:

  • Understand how a health care compliance program works.
  • Learn about consequences of Non-compliance.
  • Become familiar with enforcement entities, the scope of their authority and how to manage their visits.

Course Date

May 8th, 2014 from 12:00 pm – 1:30 pm

Who Should Attend?

  • Physicians.
  • Dentists.
  • DMEs’.
  • Rehab Facilities.
  • Ancillary Providers.
  • Home Health and Hospice providers.
  • Any medicare or medicaid provider.
- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.

Multicancer Blood Test Detects 17 Cancer Types in Large Prospective Study

A large prospective study published in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests.

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.
- Advertisement -